81 related articles for article (PubMed ID: 34692540)
1. Chemokines as Prognostic Factor in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis.
Fellhofer-Hofer J; Franz C; Vey JA; Kahlert C; Kalkum E; Mehrabi A; Halama N; Probst P; Klupp F
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791414
[TBL] [Abstract][Full Text] [Related]
2. Anticancer and anti-angiogenic activities of mannooligosaccharides extracted from coconut meal on colorectal carcinoma cells
Pason P; Tachaapaikoon C; Suyama W; Waeonukul R; Shao R; Wongwattanakul M; Limpaiboon T; Chonanant C; Ngernyuang N
Toxicol Rep; 2024 Jun; 12():82-90. PubMed ID: 38259721
[TBL] [Abstract][Full Text] [Related]
3. Systemic Immune Modulation Induced by Ephedrine in Obese-Diabetes (
Lee SH; Lee H; Park R
Curr Issues Mol Biol; 2023 Dec; 45(12):10097-10108. PubMed ID: 38132476
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil-activating Peptide 2 as a Novel Modulator of Fibrin Clot Properties in Patients with Atrial Fibrillation.
Ząbczyk M; Natorska J; Matusik PT; Mołek P; Wojciechowska W; Rajzer M; Rajtar-Salwa R; Tokarek T; Lenart-Migdalska A; Olszowska M; Undas A
Transl Stroke Res; 2023 Jun; ():1-11. PubMed ID: 37294500
[TBL] [Abstract][Full Text] [Related]
5. Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer.
Zou Q; Lei X; Xu A; Li Z; He Q; Huang X; Xu G; Tian F; Ding Y; Zhu W
Front Immunol; 2022; 13():724139. PubMed ID: 35935996
[TBL] [Abstract][Full Text] [Related]
6. Multifaceted Roles of Chemokine C-X-C Motif Ligand 7 in Inflammatory Diseases and Cancer.
Wu Q; Tu H; Li J
Front Pharmacol; 2022; 13():914730. PubMed ID: 35837284
[TBL] [Abstract][Full Text] [Related]
7. The Chemokine CXCL7 Is Related to Angiogenesis and Associated With Poor Prognosis in Colorectal Cancer Patients.
Li L; Jiang K; Li D; Li D; Fan Z; Dai G; Tu S; Liu X; Wei G
Front Oncol; 2021; 11():754221. PubMed ID: 34692540
[TBL] [Abstract][Full Text] [Related]
8. The Chemokine CXCL7 is Correlated with LDH-A and Predicts the Prognosis of Patients with Colorectal Cancer.
Liang H; Li L; Huang B; Cheng G; Ao J; Hao S
Front Biosci (Landmark Ed); 2024 Apr; 29(4):166. PubMed ID: 38682188
[TBL] [Abstract][Full Text] [Related]
9. Serum Chemokine CXCL7 as a Potential Novel Biomarker for Obstructive Colorectal Cancer.
Li L; Zhang L; Zhang T; Qi X; Cheng G; Xia L
Front Oncol; 2020; 10():599363. PubMed ID: 33643903
[TBL] [Abstract][Full Text] [Related]
10. Serum Chemokine CXCL7 as a Diagnostic Biomarker for Colorectal Cancer.
Li L; Zhang L; Tian Y; Zhang T; Duan G; Liu Y; Yin Y; Hua D; Qi X; Mao Y
Front Oncol; 2019; 9():921. PubMed ID: 31649870
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival.
Desurmont T; Skrypek N; Duhamel A; Jonckheere N; Millet G; Leteurtre E; Gosset P; Duchene B; Ramdane N; Hebbar M; Van Seuningen I; Pruvot FR; Huet G; Truant S
Cancer Sci; 2015 Mar; 106(3):262-9. PubMed ID: 25580640
[TBL] [Abstract][Full Text] [Related]
12. Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications.
Cao D; Hou M; Guan YS; Jiang M; Yang Y; Gou HF
BMC Cancer; 2009 Dec; 9():432. PubMed ID: 20003271
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
